CPLM 1.0 - Compendium of Protein Lysine ModificationTag | Content |
---|
CPLM ID | CPLM-008133 | UniProt Accession | | Genbank Protein ID | | Genbank Nucleotide ID | | Protein Name | Fatty acid synthase | Protein Synonyms/Alias | [Acyl-carrier-protein] S-acetyltransferase; [Acyl-carrier-protein] S-malonyltransferase; 3-oxoacyl-[acyl-carrier-protein] synthase; 3-oxoacyl-[acyl-carrier-protein] reductase; 3-hydroxyacyl-[acyl-carrier-protein] dehydratase; Enoyl-[acyl-carrier-protein] reductase; Oleoyl-[acyl-carrier-protein] hydrolase | Gene Name | FASN | Gene Synonyms/Alias | FAS | Created Date | July 27, 2013 | Organism | Homo sapiens (Human) | NCBI Taxa ID | 9606 | Lysine Modification | Position | Peptide | Type | References |
---|
41 | TDDDRRWKAGLYGLP | ubiquitination | [1, 2, 3, 4, 5, 6, 7, 8, 9, 10] | 70 | SFFGVHPKQAHTMDP | acetylation | [10, 11, 12] | 70 | SFFGVHPKQAHTMDP | ubiquitination | [1, 2, 3, 5, 6, 7, 8, 9, 10] | 213 | LSPEGTCKAFDTAGN | ubiquitination | [2, 3, 4, 5, 7, 10] | 235 | VVAVLLTKKSLARRV | ubiquitination | [1, 2, 3, 5, 8, 9] | 236 | VAVLLTKKSLARRVY | ubiquitination | [7] | 257 | GTNTDGFKEQGVTFP | ubiquitination | [2, 3, 7, 8, 10] | 298 | EAHGTGTKVGDPQEL | acetylation | [11, 12] | 298 | EAHGTGTKVGDPQEL | ubiquitination | [2, 3, 4, 5, 7, 8, 10] | 326 | PLLIGSTKSNMGHPE | ubiquitination | [1, 2, 3, 4, 5, 7, 8, 9, 10] | 436 | RTPEAVQKLLEQGLR | acetylation | [10, 11, 12, 13] | 436 | RTPEAVQKLLEQGLR | ubiquitination | [1, 2, 3, 4, 5, 6, 7, 8, 9, 14] | 528 | LRSDEAVKPFGLKVS | acetylation | [10, 11, 12] | 528 | LRSDEAVKPFGLKVS | ubiquitination | [1, 2, 3, 6, 7, 8, 9, 10] | 611 | YWRGQCIKEAHLPPG | ubiquitination | [7] | 631 | GLSWEECKQRCPPGV | ubiquitination | [3, 7] | 646 | VPACHNSKDTVTISG | ubiquitination | [3, 7] | 667 | EFVEQLRKEGVFAKE | ubiquitination | [2, 8] | 673 | RKEGVFAKEVRTGGM | acetylation | [10, 11, 12, 13, 15] | 673 | RKEGVFAKEVRTGGM | ubiquitination | [2, 5, 7, 8, 10] | 699 | PPLLQELKKVIREPK | ubiquitination | [8] | 776 | AVLKRGLKPSCTIIP | ubiquitination | [3, 7] | 786 | CTIIPLMKKDHRDNL | acetylation | [12] | 786 | CTIIPLMKKDHRDNL | ubiquitination | [7] | 787 | TIIPLMKKDHRDNLE | ubiquitination | [7] | 957 | GNLVVSGKVYQWDDP | ubiquitination | [8] | 992 | LAQAEVYKELRLRGY | ubiquitination | [1, 2, 3, 4, 7, 8, 9, 10] | 1065 | DPATHRQKLYTLQDK | ubiquitination | [2, 7] | 1072 | KLYTLQDKAQVADVV | acetylation | [12] | 1072 | KLYTLQDKAQVADVV | ubiquitination | [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 14] | 1116 | QQVPILEKFCFTPHT | ubiquitination | [3, 7, 10] | 1142 | QEELQLCKGLVQALQ | ubiquitination | [1, 5, 6, 7, 8, 9, 10, 14] | 1151 | LVQALQTKVTQQGLK | ubiquitination | [1, 5, 6, 7, 8, 9, 10, 14] | 1158 | KVTQQGLKMVVPGLD | ubiquitination | [1, 6, 7, 8, 9, 10, 16] | 1208 | VLAQERPKLPEDPLL | ubiquitination | [8] | 1239 | VENMPSLKMKVVEVL | acetylation | [12] | 1239 | VENMPSLKMKVVEVL | ubiquitination | [3, 5, 7, 10] | 1241 | NMPSLKMKVVEVLAG | ubiquitination | [3, 7, 8, 10] | 1392 | SLRLVGLKKSFYGST | ubiquitination | [2] | 1393 | LRLVGLKKSFYGSTL | ubiquitination | [1, 3, 6, 9] | 1429 | FRWVESLKGILADED | acetylation | [12] | 1429 | FRWVESLKGILADED | ubiquitination | [1, 2, 3, 4, 7, 8, 9, 10] | 1495 | PGSAELQKVLQGDLV | ubiquitination | [3] | 1523 | HFLLEEDKPEEPTAH | acetylation | [12] | 1523 | HFLLEEDKPEEPTAH | ubiquitination | [2, 7, 14] | 1582 | DIMLATGKLSPDAIP | acetylation | [10, 12] | 1582 | DIMLATGKLSPDAIP | ubiquitination | [2, 3, 6, 7, 8, 10] | 1591 | SPDAIPGKWTSQDSL | acetylation | [12] | 1591 | SPDAIPGKWTSQDSL | ubiquitination | [1, 2, 7, 8, 9] | 1704 | TTVGSAEKRAYLQAR | acetylation | [10, 11, 12] | 1704 | TTVGSAEKRAYLQAR | ubiquitination | [2, 3, 4, 5, 7, 8] | 1739 | VLWHTGGKGVDLVLN | ubiquitination | [2, 3, 8] | 1752 | LNSLAEEKLQASVRC | acetylation | [11, 12, 17] | 1752 | LNSLAEEKLQASVRC | ubiquitination | [2, 7, 8] | 1771 | GRFLEIGKFDLSQNH | acetylation | [11, 12, 13] | 1771 | GRFLEIGKFDLSQNH | ubiquitination | [8] | 1827 | DGVVRPLKCTVFHGA | ubiquitination | [3, 7] | 1847 | FRYMAQGKHIGKVVV | acetylation | [11, 12, 13] | 1847 | FRYMAQGKHIGKVVV | ubiquitination | [2, 7, 8, 10] | 1851 | AQGKHIGKVVVQVLA | ubiquitination | [2, 7, 8] | 1866 | EEPEAVLKGAKPKLM | ubiquitination | [1, 2, 3, 6, 7, 8, 9, 10] | 1869 | EAVLKGAKPKLMSAI | ubiquitination | [2, 3, 7, 8] | 1871 | VLKGAKPKLMSAISK | ubiquitination | [7] | 1878 | KLMSAISKTFCPAHK | ubiquitination | [1, 3, 6, 7, 9] | 1911 | LIQRGVQKLVLTSRS | ubiquitination | [1, 2, 3, 6, 7, 8, 9] | 1927 | IRTGYQAKQVRRWRR | ubiquitination | [2, 7, 8] | 1993 | EFFQDVCKPKYSGTL | ubiquitination | [2, 3, 5, 7, 10] | 1995 | FQDVCKPKYSGTLNL | acetylation | [11, 12] | 1995 | FQDVCKPKYSGTLNL | ubiquitination | [3, 7, 10] | 2047 | AMERICEKRRHEGLP | ubiquitination | [2] | 2186 | VRQLTLRKLQELSSK | ubiquitination | [2, 14] | 2193 | KLQELSSKADEASEL | ubiquitination | [3] | 2206 | ELACPTPKEDGLAQQ | ubiquitination | [3, 14] | 2391 | LEALLPLKGLEERVA | acetylation | [12] | 2391 | LEALLPLKGLEERVA | ubiquitination | [1, 2, 5, 6, 7, 8, 9, 10] | 2406 | AAVDLIIKSHQGLDR | ubiquitination | [7] | 2426 | AARSFYYKLRAAEQY | ubiquitination | [3, 7] | 2436 | AAEQYTPKAKYHGNV | acetylation | [10] | 2436 | AAEQYTPKAKYHGNV | ubiquitination | [2, 7] | 2438 | EQYTPKAKYHGNVML | ubiquitination | [6, 7] | 2449 | NVMLLRAKTGGAYGE | ubiquitination | [1, 2, 3, 6, 7, 8, 9, 10, 14] | 2471 | LSQVCDGKVSVHVIE | ubiquitination | [7] |
| Reference | [1] A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, Mann M, Choudhary C. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284. [ PMID: 21890473] [2] Systematic and quantitative assessment of the ubiquitin-modified proteome. Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, Harper JW, Gygi SP. Mol Cell. 2011 Oct 21;44(2):325-40. [ PMID: 21906983] [3] Global identification of modular cullin-RING ligase substrates. Emanuele MJ, Elia AE, Xu Q, Thoma CR, Izhar L, Leng Y, Guo A, Chen YN, Rush J, Hsu PW, Yen HC, Elledge SJ. Cell. 2011 Oct 14;147(2):459-74. [ PMID: 21963094] [4] Ubiquitin ligase substrate identification through quantitative proteomics at both the protein and peptide levels. Lee KA, Hammerle LP, Andrews PS, Stokes MP, Mustelin T, Silva JC, Black RA, Doedens JR. J Biol Chem. 2011 Dec 2;286(48):41530-8. [ PMID: 21987572] [5] Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition. Udeshi ND, Mani DR, Eisenhaure T, Mertins P, Jaffe JD, Clauser KR, Hacohen N, Carr SA. Mol Cell Proteomics. 2012 May;11(5):148-59. [ PMID: 22505724] [6] Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. Povlsen LK, Beli P, Wagner SA, Poulsen SL, Sylvestersen KB, Poulsen JW, Nielsen ML, Bekker-Jensen S, Mailand N, Choudhary C. Nat Cell Biol. 2012 Oct;14(10):1089-98. [ PMID: 23000965] [7] Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments. Udeshi ND, Svinkina T, Mertins P, Kuhn E, Mani DR, Qiao JW, Carr SA. Mol Cell Proteomics. 2013 Mar;12(3):825-31. [ PMID: 23266961] [8] Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Sarraf SA, Raman M, Guarani-Pereira V, Sowa ME, Huttlin EL, Gygi SP, Harper JW. Nature. 2013 Apr 18;496(7445):372-6. [ PMID: 23503661] [9] hCKSAAP_UbSite: improved prediction of human ubiquitination sites by exploiting amino acid pattern and properties. Chen Z, Zhou Y, Song J, Zhang Z. Biochim Biophys Acta. 2013 Aug;1834(8):1461-7. [ PMID: 23603789] [10] Integrated proteomic analysis of post-translational modifications by serial enrichment. Mertins P, Qiao JW, Patel J, Udeshi ND, Clauser KR, Mani DR, Burgess MW, Gillette MA, Jaffe JD, Carr SA. Nat Methods. 2013 Jul;10(7):634-7. [ PMID: 23749302] [11] Lysine acetylation targets protein complexes and co-regulates major cellular functions. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M. Science. 2009 Aug 14;325(5942):834-40. [ PMID: 19608861] [12] Proteomic investigations of lysine acetylation identify diverse substrates of mitochondrial deacetylase sirt3. Sol EM, Wagner SA, Weinert BT, Kumar A, Kim HS, Deng CX, Choudhary C. PLoS One. 2012;7(12):e50545. [ PMID: 23236377] [13] Monoclonal antibody cocktail as an enrichment tool for acetylome analysis. Shaw PG, Chaerkady R, Zhang Z, Davidson NE, Pandey A. Anal Chem. 2011 May 15;83(10):3623-6. [ PMID: 21466224] [14] Proteome-wide identification of ubiquitylation sites by conjugation of engineered lysine-less ubiquitin. Oshikawa K, Matsumoto M, Oyamada K, Nakayama KI. J Proteome Res. 2012 Feb 3;11(2):796-807. [ PMID: 22053931] [15] Proteomic investigations reveal a role for RNA processing factor THRAP3 in the DNA damage response. Beli P, Lukashchuk N, Wagner SA, Weinert BT, Olsen JV, Baskcomb L, Mann M, Jackson SP, Choudhary C. Mol Cell. 2012 Apr 27;46(2):212-25. [ PMID: 22424773] [16] A data set of human endogenous protein ubiquitination sites. Shi Y, Chan DW, Jung SY, Malovannaya A, Wang Y, Qin J. Mol Cell Proteomics. 2011 May;10(5):M110.002089. [ PMID: 20972266] [17] Regulation of cellular metabolism by protein lysine acetylation. Zhao S, Xu W, Jiang W, Yu W, Lin Y, Zhang T, Yao J, Zhou L, Zeng Y, Li H, Li Y, Shi J, An W, Hancock SM, He F, Qin L, Chin J, Yang P, Chen X, Lei Q, Xiong Y, Guan KL. Science. 2010 Feb 19;327(5968):1000-4. [ PMID: 20167786] | Functional Description | Fatty acid synthetase catalyzes the formation of long- chain fatty acids from acetyl-CoA, malonyl-CoA and NADPH. This multifunctional protein has 7 catalytic activities and an acyl carrier protein. | Sequence Annotation | DOMAIN 2123 2179 Acyl carrier. NP_BIND 1671 1688 NADP (ER) (By similarity). NP_BIND 1886 1901 NADP (KR) (By similarity). REGION 1 414 Beta-ketoacyl synthase (By similarity). REGION 429 817 Acyl and malonyl transferases (By REGION 1635 1863 Enoyl reductase (By similarity). REGION 1864 2118 Beta-ketoacyl reductase (By similarity). REGION 2207 2511 Thioesterase (By similarity). ACT_SITE 161 161 For beta-ketoacyl synthase activity (By ACT_SITE 581 581 For malonyltransferase activity (By ACT_SITE 878 878 For beta-hydroxyacyl dehydratase activity ACT_SITE 2308 2308 For thioesterase activity. ACT_SITE 2481 2481 For thioesterase activity (By MOD_RES 1 1 N-acetylmethionine. MOD_RES 70 70 N6-acetyllysine. MOD_RES 207 207 Phosphoserine. MOD_RES 298 298 N6-acetyllysine. MOD_RES 436 436 N6-acetyllysine. MOD_RES 528 528 N6-acetyllysine. MOD_RES 673 673 N6-acetyllysine. MOD_RES 1704 1704 N6-(pyridoxal phosphate)lysine; alternate MOD_RES 1704 1704 N6-acetyllysine; alternate. MOD_RES 1771 1771 N6-acetyllysine. MOD_RES 1847 1847 N6-acetyllysine. MOD_RES 1995 1995 N6-acetyllysine. MOD_RES 2156 2156 O-(pantetheine 4'-phosphoryl)serine (By MOD_RES 2198 2198 Phosphoserine. MOD_RES 2204 2204 Phosphothreonine. MOD_RES 2236 2236 Phosphoserine. | Keyword | 3D-structure; Acetylation; Complete proteome; Cytoplasm; Direct protein sequencing; Fatty acid biosynthesis; Fatty acid metabolism; Hydrolase; Lipid biosynthesis; Lipid metabolism; Lyase; Multifunctional enzyme; NAD; NADP; Oxidoreductase; Phosphopantetheine; Phosphoprotein; Polymorphism; Pyridoxal phosphate; Reference proteome; Transferase. | Sequence Source | UniProt (SWISSPROT/TrEMBL); GenBank; EMBL | Protein Length | 2511 AA | Protein Sequence | MEEVVIAGMS GKLPESENLQ EFWDNLIGGV DMVTDDDRRW KAGLYGLPRR SGKLKDLSRF 60 DASFFGVHPK QAHTMDPQLR LLLEVTYEAI VDGGINPDSL RGTHTGVWVG VSGSETSEAL 120 SRDPETLVGY SMVGCQRAMM ANRLSFFFDF RGPSIALDTA CSSSLMALQN AYQAIHSGQC 180 PAAIVGGINV LLKPNTSVQF LRLGMLSPEG TCKAFDTAGN GYCRSEGVVA VLLTKKSLAR 240 RVYATILNAG TNTDGFKEQG VTFPSGDIQE QLIRSLYQSA GVAPESFEYI EAHGTGTKVG 300 DPQELNGITR ALCATRQEPL LIGSTKSNMG HPEPASGLAA LAKVLLSLEH GLWAPNLHFH 360 SPNPEIPALL DGRLQVVDQP LPVRGGNVGI NSFGFGGSNV HIILRPNTQP PPAPAPHATL 420 PRLLRASGRT PEAVQKLLEQ GLRHSQDLAF LSMLNDIAAV PATAMPFRGY AVLGGERGGP 480 EVQQVPAGER PLWFICSGMG TQWRGMGLSL MRLDRFRDSI LRSDEAVKPF GLKVSQLLLS 540 TDESTFDDIV HSFVSLTAIQ IGLIDLLSCM GLRPDGIVGH SLGEVACGYA DGCLSQEEAV 600 LAAYWRGQCI KEAHLPPGAM AAVGLSWEEC KQRCPPGVVP ACHNSKDTVT ISGPQAPVFE 660 FVEQLRKEGV FAKEVRTGGM AFHSYFMEAI APPLLQELKK VIREPKPRSA RWLSTSIPEA 720 QWHSSLARTS SAEYNVNNLV SPVLFQEALW HVPEHAVVLE IAPHALLQAV LKRGLKPSCT 780 IIPLMKKDHR DNLEFFLAGI GRLHLSGIDA NPNALFPPVE FPAPRGTPLI SPLIKWDHSL 840 AWDVPAAEDF PNGSGSPSAA IYNIDTSSES PDHYLVDHTL DGRVLFPATG YLSIVWKTLA 900 RALGLGVEQL PVVFEDVVLH QATILPKTGT VSLEVRLLEA SRAFEVSENG NLVVSGKVYQ 960 WDDPDPRLFD HPESPTPNPT EPLFLAQAEV YKELRLRGYD YGPHFQGILE ASLEGDSGRL 1020 LWKDNWVSFM DTMLQMSILG SAKHGLYLPT RVTAIHIDPA THRQKLYTLQ DKAQVADVVV 1080 SRWLRVTVAG GVHISGLHTE SAPRRQQEQQ VPILEKFCFT PHTEEGCLSE RAALQEELQL 1140 CKGLVQALQT KVTQQGLKMV VPGLDGAQIP RDPSQQELPR LLSAACRLQL NGNLQLELAQ 1200 VLAQERPKLP EDPLLSGLLD SPALKACLDT AVENMPSLKM KVVEVLAGHG HLYSRIPGLL 1260 SPHPLLQLSY TATDRHPQAL EAAQAELQQH DVAQGQWDPA DPAPSALGSA DLLVCNCAVA 1320 ALGDPASALS NMVAALREGG FLLLHTLLRG HPLGDIVAFL TSTEPQYGQG ILSQDAWESL 1380 FSRVSLRLVG LKKSFYGSTL FLCRRPTPQD SPIFLPVDDT SFRWVESLKG ILADEDSSRP 1440 VWLKAINCAT SGVVGLVNCL RREPGGNRLR CVLLSNLSST SHVPEVDPGS AELQKVLQGD 1500 LVMNVYRDGA WGAFRHFLLE EDKPEEPTAH AFVSTLTRGD LSSIRWVCSS LRHAQPTCPG 1560 AQLCTVYYAS LNFRDIMLAT GKLSPDAIPG KWTSQDSLLG MEFSGRDASG KRVMGLVPAK 1620 GLATSVLLSP DFLWDVPSNW TLEEAASVPV VYSTAYYALV VRGRVRPGET LLIHSGSGGV 1680 GQAAIAIALS LGCRVFTTVG SAEKRAYLQA RFPQLDSTSF ANSRDTSFEQ HVLWHTGGKG 1740 VDLVLNSLAE EKLQASVRCL ATHGRFLEIG KFDLSQNHPL GMAIFLKNVT FHGVLLDAFF 1800 NESSADWREV WALVQAGIRD GVVRPLKCTV FHGAQVEDAF RYMAQGKHIG KVVVQVLAEE 1860 PEAVLKGAKP KLMSAISKTF CPAHKSYIIA GGLGGFGLEL AQWLIQRGVQ KLVLTSRSGI 1920 RTGYQAKQVR RWRRQGVQVQ VSTSNISSLE GARGLIAEAA QLGPVGGVFN LAVVLRDGLL 1980 ENQTPEFFQD VCKPKYSGTL NLDRVTREAC PELDYFVVFS SVSCGRGNAG QSNYGFANSA 2040 MERICEKRRH EGLPGLAVQW GAIGDVGILV ETMSTNDTIV SGTLPQRMAS CLEVLDLFLN 2100 QPHMVLSSFV LAEKAAAYRD RDSQRDLVEA VAHILGIRDL AAVNLDSSLA DLGLDSLMSV 2160 EVRQTLEREL NLVLSVREVR QLTLRKLQEL SSKADEASEL ACPTPKEDGL AQQQTQLNLR 2220 SLLVNPEGPT LMRLNSVQSS ERPLFLVHPI EGSTTVFHSL ASRLSIPTYG LQCTRAAPLD 2280 SIHSLAAYYI DCIRQVQPEG PYRVAGYSYG ACVAFEMCSQ LQAQQSPAPT HNSLFLFDGS 2340 PTYVLAYTQS YRAKLTPGCE AEAETEAICF FVQQFTDMEH NRVLEALLPL KGLEERVAAA 2400 VDLIIKSHQG LDRQELSFAA RSFYYKLRAA EQYTPKAKYH GNVMLLRAKT GGAYGEDLGA 2460 DYNLSQVCDG KVSVHVIEGD HRTLLEGSGL ESIISIIHSS LAEPRVSVRE G 2511 | Gene Ontology | GO:0005829; C:cytosol; TAS:Reactome. GO:0042587; C:glycogen granule; IEA:Compara. GO:0005794; C:Golgi apparatus; IDA:HPA. GO:0042470; C:melanosome; IEA:UniProtKB-SubCell. GO:0005739; C:mitochondrion; IEA:Compara. GO:0005886; C:plasma membrane; IDA:HPA. GO:0047451; F:3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity; IEA:EC. GO:0004317; F:3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity; IEA:InterPro. GO:0004316; F:3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; IEA:EC. GO:0004315; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; IEA:EC. GO:0004313; F:[acyl-carrier-protein] S-acetyltransferase activity; IEA:EC. GO:0004314; F:[acyl-carrier-protein] S-malonyltransferase activity; IEA:EC. GO:0008144; F:drug binding; IEA:Compara. GO:0004319; F:enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity; IEA:EC. GO:0004312; F:fatty acid synthase activity; TAS:Reactome. GO:0016295; F:myristoyl-[acyl-carrier-protein] hydrolase activity; IEA:EC. GO:0070402; F:NADPH binding; IEA:Compara. GO:0004320; F:oleoyl-[acyl-carrier-protein] hydrolase activity; IEA:EC. GO:0016296; F:palmitoyl-[acyl-carrier-protein] hydrolase activity; IEA:EC. GO:0008270; F:zinc ion binding; IEA:InterPro. GO:0006084; P:acetyl-CoA metabolic process; IEA:Compara. GO:0006112; P:energy reserve metabolic process; TAS:Reactome. GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW. GO:0006631; P:fatty acid metabolic process; TAS:ProtInc. GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome. GO:0015939; P:pantothenate metabolic process; TAS:Reactome. GO:0031325; P:positive regulation of cellular metabolic process; TAS:Reactome. GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome. | Interpro | | Pfam | | SMART | | PROSITE | | PRINTS | |
|